Fig. 5From: MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarctionHistological analysis of inflammation and fibrosis in each group. MI was constructed through ligating the left anterior descending artery and then injecting 1 × 106 different MSCs in 20 μl PBS into the peri-infarcted zones. Heart samples harvested 7 or 28 days after cell injection. a H&E staining of rat heart sections collected at 7 and 28 days post MI. b Masson trichrome staining of heart slides at 7 and 28 days after MI: red, myocardium; blue, scarred fibrosis. c Percentage of fibrotic area calculated and averaged by ImageJ software (n = 5). d Western blot analysis of collagen I and α-SMA protein detected in LV. *p < 0.05 compared with vector-MSC group. MSC mesenchymal stem cell, PBS phosphate-buffered salineBack to article page